Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples ; volume:39 ; number:1 ; day:24 ; month:6 ; year:2020 ; pages:1 ; date:12.2020
Journal of experimental & clinical cancer research ; 39, Heft 1 (24.6.2020), 1, 12.2020
- Urheber
-
Russano, Marco
Napolitano, Andrea
Ribelli, Giulia
Iuliani, Michele
Simonetti, Sonia
Citarella, Fabrizio
Pantano, Francesco
Dell’Aquila, Emanuela
Anesi, Cecilia
Silvestris, Nicola
Argentiero, Antonella
Solimando, Antonio Giovanni
Vincenzi, Bruno
Tonini, Giuseppe
Santini, Daniele
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-020-01615-w
- URN
-
urn:nbn:de:101:1-2020082021071958039407
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Russano, Marco
- Napolitano, Andrea
- Ribelli, Giulia
- Iuliani, Michele
- Simonetti, Sonia
- Citarella, Fabrizio
- Pantano, Francesco
- Dell’Aquila, Emanuela
- Anesi, Cecilia
- Silvestris, Nicola
- Argentiero, Antonella
- Solimando, Antonio Giovanni
- Vincenzi, Bruno
- Tonini, Giuseppe
- Santini, Daniele
- SpringerLink (Online service)
Ähnliche Objekte (12)
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA
In situ 10-cell RNA sequencing in tissue and tumor biopsy samples
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
Primary and metastatic tumor dormancy as a result of population heterogeneity
Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples
Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
Tumor‐On‐A‐Chip Model Incorporating Human‐Based Hydrogels for Easy Assessment of Metastatic Tumor Inter‐Heterogeneity
BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA
In situ 10-cell RNA sequencing in tissue and tumor biopsy samples
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
Primary and metastatic tumor dormancy as a result of population heterogeneity
Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples
Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
Tumor‐On‐A‐Chip Model Incorporating Human‐Based Hydrogels for Easy Assessment of Metastatic Tumor Inter‐Heterogeneity
BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA
In situ 10-cell RNA sequencing in tissue and tumor biopsy samples
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
Primary and metastatic tumor dormancy as a result of population heterogeneity
Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples
Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
Tumor‐On‐A‐Chip Model Incorporating Human‐Based Hydrogels for Easy Assessment of Metastatic Tumor Inter‐Heterogeneity